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Background: The birth weight of Black neonates in the United States is consistently smaller than that of their
White counterparts. Epigenetic differences between the races may be involved in such disparities. The goal of these
analyses was to model the role of IGF1 methylation in mediating the association between race and birth weight.
Data was collected on a cohort of 87 live born infants. IGF1 methylation was measured in DNA isolated from the
mononuclear fraction of umbilical cord blood collected after delivery. Quantitative, loci-specific methylation was
assessed using the Infinium HumanMethylation27 BeadArray (Illumina Inc., San Diego, CA). Locus specific
methylation of the IGF1 CpG site was validated on a subset of the original sample (N = 61) using pyrosequencing.
Multiple linear regression was used to examine relationships between IGF1 methylation, race, and birth weight. A
formal mediation analysis was then used to estimate the relationship of IGF1 methylation to race and birth weight.
Results: Black race was associated with a 7.45% decrease in gestational age-adjusted birth weight (aBW) (P = 0.04)
and Black infants had significantly higher IGF1 methylation than non-Black infants (P < 0.05). A one standard
deviation increase in IGF1 methylation was associated with a 3.32% decrease in aBW (P = 0.02). Including IGF1
methylation as a covariate, the effect of Black race on aBW was attenuated. A formal mediation analysis showed
that the controlled direct effect of Black race on aBW was −6.26% (95% CI = −14.15, 1.06); the total effect of Black
race on IGF1 methylation was −8.12% (95% CI = −16.08, −0.55); and the natural indirect effect of Black race on aBW
through IGF1 methylation was −1.86% (95% CI = −5.22, 0.18)
Conclusion: The results of the mediation analysis along with the multivariable regression analyses suggest that
IGF1 methylation may partially mediate the relationship between Black race and aBW. Such epigenetic differences
may be involved in racial disparities observed in perinatal outcomes.
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Racial differences in birth outcomes and their health
consequences remain among the most persistent and
vexing disparities in the United States [1]. For example,
Black infants have consistently been shown to have
smaller birth weights than their White counterparts [1].
Growing evidence suggests that such perinatal factors
can impact health across the life course, including an in-
creased risk of higher blood pressure, insulin resistance* Correspondence: vmisra@med.wayne.edu
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unless otherwise stated.and diabetes, abnormal cholesterol profiles, pathologic
patterns of fat deposition, and an elevated risk of coron-
ary vascular disease later in life [2]. There is growing evi-
dence that epigenetic changes may mediate the effects of
the prenatal environments on short- and long-term
health outcomes of the offspring [3].
DNA methylation is an important epigenetic mechan-
ism that helps regulate gene expression and can be influ-
enced by both the environment and the genome. DNA
methylation has also been linked to some cancers, com-
plex diseases, and transgenerational effects, and may
serve as a potential link between the genome, environ-
ment, and disease [4-7]. On a population level, DNA
methylation profiles differ across African and European
ancestral groups [8]. For example, both at birth and in
adulthood, African-Americans have lower genome-widetral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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Table 1 Maternal and infant characteristics of the cohort
by race
Non-Black Black
N % N % P value
Sample Size 66 75.9 21 24.1
Adequate prenatal care
No 13 19.7 6 28.6 0.38
Yes 53 80.3 15 71.4
Parity
Multiparous 43 65.2 16 76.2 0.43
Nulliparous 23 34.9 5 23.8
Prenatal vitamin use
No 10 15.2 6 28.6 0.20
Yes 56 84.9 15 71.4
Smoker
No 58 87.9 18 85.7 0.72
Yes 8 12.1 3 14.3
Infant gender
Female 28 42.4 11 52.4 0.46
Male 38 57.6 10 47.6
Mean ± SD Mean ± SD
Maternal age (years) 29.2 ± 6.6 25.6 ± 4.6 0.02
Gestational age (weeks) 38.0 ± 2.4 38.4 ± 1.7 0.49
aBW (grams) 3294.2 ± 455.0 3064.5 ± 483.3 0.04
IGF1 methylation 0.26 ± 0.05 0.29 ± 0.06 0.03
Abbr: aBW = gestational age-adjusted birthweight; SD = standard deviation.
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European ancestry [9,10]. Such differences may contribute
to health disparities observed between the two groups
across the life course [11,12]. However, surprisingly few
studies have explored racial differences in DNA methyla-
tion at birth [9].
Among epigenetically regulated genes, the insulin-like
growth factors, including IGF1 and IGF2, have particu-
larly important roles in fetal and placental growth
[13-17]. Loss of Igf1 expression is associated with de-
creased fetal growth in mice [13]. Similarly, IUGR in the
rat was associated with altered epigenetic characteristics
of the Igf1 gene, altered Igf1 expression, and reduced
IGF1 levels in liver and blood [16]. Partial deletion of
IGF1 in humans has been associated with impaired pre-
and postnatal growth [15], while growth-restricted in-
fants have been shown to have lower umbilical cord
blood levels of IGF1 compared to their counterparts
with normal growth [17].
The well-established effects of IGF1 on birth weight
along with persistently reported racial differences in
birth weight and in genome-wide methylation studies
have led us to examine the role of IGF1 methylation in
the pathway between race and birth weight. We hypoth-
esized that IGF1 methylation may partially explain racial
differences in birth weight by mediating the association
between race and birth weight. Indeed, our analyses
demonstrated that IGF1 methylation partially mediates
the relationship between Black race and gestational age-
adjusted birth weight (aBW). These results suggest that
such epigenetic differences may be involved in racial
disparities observed in perinatal outcomes.
Results
Ninety mother-infant pairs were eligible for inclusion in
this analysis. The analysis is restricted to 87 mother-
infant pairs for whom race is known. Demographic and
health characteristics of the 87 infants and their
mothers are presented in Table 1. Approximately 24%
of the mothers were Black and 76% were non-Black.
Black and non-Black mothers were similar for several of
the demographic and clinical characteristics considered.
A majority of the women had adequate prenatal care
and took prenatal vitamins. However, Black mothers
were slightly younger than non-Black mothers (mean
age 25.6 and 29.2 years, respectively; P = 0.02). While
there were not any statistically significant differences in
gestational age between the two groups, Black infants
had a smaller mean gestational age-adjusted birth weight
(P = 0.04).
As shown in Table 1, Black infants had significantly
higher IGF1 methylation when compared to their non-
Black counterparts, (P = 0.03). In Table 2, we analyzed
IGF1 methylation and birth weight by maternal and infantcharacteristics. IGF1 methylation did not differ by
adequacy of prenatal care, parity, maternal vitamin use,
smoking status, or infant gender. In contrast, birth weight
and gestational age-adjusted birth weight were associated
with both parity and infant gender as expected.
We modeled the relationships between race, IGF1
methylation, and gestational age-adjusted birth weight
using multivariable linear regression. Figure 1 shows the
overall relationship of aBW to IGF1 methylation depict-
ing the individual values by race. Using regression
models, IGF1 methylation may be considered as a poten-
tial mediator of the relationship between race and aBW
if several criteria are satisfied [18]: (a) there is a signifi-
cant relationship between the independent variable
(race) and the mediator (IGF1 methylation); (b) there is
a significant relationship between the mediator (IGF1
methylation) and the outcome (aBW); (c) the independ-
ent variable (race) significantly affects the outcome
(aBW); and (d) the effect of the previously significant re-
lationship between the independent variable (race) and
the outcome (aBW) is no longer significant when con-
trolled for the mediator (IGF1 methylation).
Table 2 The relationship of IGF1 methylation and birth weight to select maternal and infant characteristics
IGF1 methylation BW (grams) aBW (grams)
Mean ± SD Mean ± SD Mean ± SD
Adequate prenatal care
No 0.27 ± 0.06 3060.8 ± 773.3 3161.4 ± 500.5
Yes 0.26 ± 0.05 3274.6 ± 623.5 3260.3 ± 462.2
Parity
multiparous 0.27 ± 0.05 3381.8 ± 531.6** 3331.7 ± 451.3**
nulliparous 0.26 ± 0.06 2903.8 ± 787.8 3042.8 ± 454.1
Prenatal vitamin use
No 0.27 ± 0.05 3135.3 ± 568.5 3183.1 ± 343.9
Yes 0.26 ± 0.06 3248.8 ± 681.1 3251.2 ± 494.7
Smoker
No 0.27 ± 0.06 3245.7 ± 662.4 3253.0 ± 437.9
Yes 0.26 ± 0.05 3105.0 ± 662.3 3139.7 ± 668.0
Infant gender
Female 0.26 ± 0.07 2959.2 ± 721.0** 3090.2 ± 442.6*
Male 0.27 ± 0.04 3446.3 ± 518.4 3359.4 ± 460.4
Maternal age
<30 0.27 ± 0.06 3123.8 ± 758.5 3210.7 ± 490.2
≥30 0.26 ± 0.05 3382.6 ± 445.4 3280.3 ± 440.9
Abbr: BW = birth weight; aBW = gestational age-adjusted birth weight; SD = standard deviation.
*P < 0.05.
**P < 0.01.
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7.45% decrease in aBW (P = 0.04) after adjustment for ma-
ternal age, parity, and infant gender, and a 0.62 unit stand-
ard deviation increase in methylation of IGF1 (P = 0.02)
after adjusting for maternal age. A one standard deviationFigure 1 The relationship between gestational age-adjusted birth
weight (aBW) and IGF1 methylation. The open circles represent
Blacks and the closed circles represent non-Blacks.increase in IGF1 methylation was associated with a
3.32% decrease in aBW (P = 0.02). The effect of Black
race on aBW was attenuated and no longer significant
(β = −5.68%, 95% CI = −12.84, 1.49) after including IGF1
methylation as a covariate to the model. Thus, these re-
sults suggest that IGF1 methylation may be a potential
mediator of the relationship between race and aBW [18].
As such, we used mediation analysis (see ‘Methods’) to
formally test the hypothesis that IGF1 methylation medi-
ates the relationship between race and aBW as shown in
Figure 2 [18]. These analyses were controlled for mater-
nal age, parity, and infant gender. In this model, the total
effect (Figure 2A) relating race and aBW was −8.12% (95%
CI = −16.08, −0.55). The controlled direct effect relating
race to aBW after adjusting for IGF1 methylation status
(Figure 2B) was −6.26% (95% CI = −14.15, 1.06). Using
these results, the natural indirect effect was −1.86% (95%
CI = −5.22, 0.18). The smaller direct effect (−6.26%) com-
pared to the total effect (−8.12%) suggests that IGF1
methylation partially mediates the relationship between
Black race and aBW and that the mediation model ap-
proaches significance.Discussion
The primary aim of these analyses was to model the role
of IGF1 methylation as a mediator of the relationship
Table 3 The relationships between race, IGF1 methylation, and gestational age-adjusted birth weight1
IGF1 Methylation2 % change in aBW3
β 95% CI P value β 95% CI P value
Race
Black race 0.62 0.11, 1.12 0.02 −7.45% −14.44, −0.45 0.04
IGF1 methylation
Methylation z-score - - - −3.32% −6.17, −0.47 0.02
Joint effects
Black race - - - −5.68% −12.84, 1.49 0.12
Methylation z-score - - - −2.70% −5.63, 0.24 0.07
1Modeled using standard multivariable linear regression; 2IGF1 methylation z-score controlled for maternal age; 3gestational age-adjusted birth weight (aBW)
controlled for maternal age, parity, and infant gender.
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Black infants have lower mean birth weights than other
racial groups in the United States, even after controlling
for gestational age. Our data are consistent with these
prior observations. It has been thought that epigenetic
changes may mediate the effects of adverse birth out-
comes on health outcomes of the offspring. Building on
these observations, we found that Black infants had
higher IGF1 methylation than their non-Black counter-
parts and that IGF1 methylation was significantly associ-
ated with birth weight (Table 3). A formal mediation
analysis (Figure 2) suggests that methylation of the IGF1
gene partially mediates the association between Black
race and aBW. Moreover, the magnitude of the indirect
effect is moderate in size.
The underlying reason for racial differences in DNA
methylation levels, specifically at the IGF1 locus, at birth
is not known. Such methylation differences may reflect
variations in the intrauterine environment, including
variation by race in maternal or fetal metabolism, gen-
omic signals for methylation, or environmental expo-
sures. Methylation differences by race may also be
related to race-specific variation in the distribution of
cell types in the mononuclear fraction of cord bloodFigure 2 Models for mediation analysis for the relationship of Black race, IG
unmediated model used to calculate the total effect. (B) The mediated mode
coefficients for the total effect, χ’, and the controlled direct effect, χ, are given[19]. Differentiating these factors is beyond the scope of
our current study. Irrespective of the mechanism, we
hypothesize that DNA methylation differences between
races may be related to variation in gene expression by
race that influence birth weight and, ultimately, risk of
disease across the life course.
Consistent with many prior studies suggesting a rela-
tionship between variation in IGF1 expression and birth
weight [15,17], our analyses suggest that the higher level
of methylation of the IGF1 was significantly associated
with a decrease in aBW (Table 3). While we did not
measure IGF1 expression per se, the assessed methyla-
tion site was near the transcription start site and might
be theoretically expected to result in altered expression.
It is important to note that IGF1 is regulated by two
promoters and multiple transcription start sites [20].
The complex structure of IGF1 makes specific inferences
regarding gene expression difficult. Thus additional
studies are needed to evaluate how differences in methy-
lation at this and other nearby CpG sites may differen-
tially influence IGF1 expression generally and by race.
Finally, our analyses suggest that the higher level of
methylation of the IGF1 locus in Black infants accounts
for at least part of the disparity in infant birth weight.F1 methylation and gestational age-adjusted birth weight. (A) The
l used to calculate the controlled direct effect. The calculated regression
.
Straughen et al. Clinical Epigenetics  (2015) 7:47 Page 5 of 7Most prior research in this area focuses on relations be-
tween the two variables considered separately, and much
has been written about the relationship between either
race or methylation and their effects on birth weight.
Our work is the first to formally model the mediation of
the relation between race and birth weight by locus spe-
cific methylation.
In our model, we specifically hypothesize that IGF1
methylation is in a causal sequence between race and
birth weight. The statistical power to detect mediated ef-
fects using these models is typically low [21]. However,
while our sample size may not be sufficiently large to
achieve statistical significance, analysis of the causal
steps in the process using regression models and the for-
mal mediation model suggests that IGF1 methylation
partially mediates the relationship between Black race
and aBW [22,23]. That is to say, based on established
criteria, partial mediation is likely to be present given
the following: the total effect of race on aBW is signifi-
cant; the effect of race on IGF1 methylation is signifi-
cant; the effect of IGF1 methylation on aBW controlled
for race is significant; and, most importantly, the direct
effect of race on aBW adjusted for IGF1 methylation is
non-significant and smaller than the total effect. The
finding of partial mediation implies that other indirect
effects are also likely to have a role in mediating racial
differences in birth weight.Conclusions
Racial disparities in birth outcomes remain one of the
most vexing public health problems in the United States.
Our analyses suggest that IGF1 methylation partially me-
diates observed racial disparities in birth weight. Our re-
sults add to emerging evidence that epigenetic profiles
appear to differ across racial groups [10,24,25] and that
these differences may contribute to phenotypic differ-
ences, such as discordant birth weights. However, birth
weight is a complex phenotype influenced by many fac-
tors including maternal characteristics, environmental
exposures, psychosocial stressors, and infant characteris-
tics. Thus, variation in size at birth results from inter-
action between maternal genetic factors, fetal genetic
factors, the maternal (external) environment, and the
intrauterine environment. There may also be effects as-
sociated with maternal and paternally derived imprinted
fetal genes. While our study did not measure many of
these distal factors, our results suggest that they are
likely to have a complementary role in mediating racial
differences in birth weight. However, differences in DNA
methylation and their influence on fetal growth may also
represent the end result of the interaction among many
of these factors. A more comprehensive examination of
the role of epigenetics in the context of these otherfactors and their influence on racial disparities in peri-
natal outcomes is warranted.
Methods
Study sample and data collection
Data and biological samples were collected as part of a
larger study at Tampa General Hospital in Tampa,
Florida. The University of South Florida Institutional Re-
view Board approved this study. All infants born at
Tampa General Hospital were initially eligible for inclu-
sion into the study; however, infants born to women
whose prenatal tests indicated that they were HIV or
Hepatitis B positive were excluded. Samples used for this
analysis were restricted to live born, singleton infants
without known birth defects. Demographic and clinical
variables were abstracted from the medical record using
standardized forms as part of the parent study. These
variables included the following: gestational age (based
on clinical estimate and the date of last menstrual
period), infant birth weight, infant gender, pregnancy
complications, vitamin use, presence of birth defects,
plurality, parity, gravidity, prenatal care usage (adequate
or not as recorded in the medical record), maternal age,
and race (classified as Black or non-Black). Umbilical
cord blood samples were collected after delivery into
standard EDTA collection tubes. The mononuclear frac-
tion was isolated via Ficoll-Paque density gradient cen-
trifugation within 24 hours of sample collection. After
separation, the mononuclear layer was suspended in
fetal bovine serum and 10% DMSO and stored at −80°C
until analysis.
DNA isolation and methylation analysis
DNA isolation and methylation assessment were con-
ducted by the Wayne State University Applied Genomics
Technology Center. DNA was isolated from the mo-
nonuclear fraction of umbilical cord blood using the
Qiagen EZ1 DNA tissue kit (Qiagen, Valencia, CA, USA)
according to the method of Lum et al. with the excep-
tion that PBS was substituted for TE buffer [26]. Bisulfite
modified DNA was prepared using the EZ-96 DNA
Methylation Kit™ (Zymo Research Corp., Irvine, CA,
USA) according to the manufacturer’s instructions. Quan-
titative, loci-specific methylation was assessed using the
Infinium HumanMethylation27 BeadArray (Illumina Inc.,
San Diego, CA, USA) per the manufacturer’s instructions.
The array interrogates 27,578 loci located in more
than 14,000 genes. For each CpG (cytosine-guanine di-
nucleotide) site, two different probes (one against the
methylated site and one against the unmethylated site)
were hybridized with the bisulfite-modified DNA. Next,
a single-base extension added one of two possible fluor-
escent probes (one for methylated (C) and one for
unmethylated (T) alleles). Methylation status was then
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the ratio of fluorescent signals from methylated to the
sum of methylated and unmethylated probes and
ranges from 0 (unmethylated) to 1 (methylated). Back-
ground normalization was done using the GenomeStudio
Methylation module according to the guidelines recom-
mended by Illumina. In short, this method subtracts the
average signal of the negative control bead types from the
probe signals. Normalized beta values were then output
for use in subsequent analyses. In this study, our a
priori hypotheses focused on the methylation status of
IGF1; therefore, we analyzed one CpG locus associated
with this gene. The nucleotide position of the IGF1
CpG locus was chr12:101,398,416 according to the
NCBI build 36.1.
A subset of samples was run in duplicate in order to
assess inter-chip variability. In addition, CpGenome Uni-
versal Methylated DNA was used as a positive control
(Millipore, Temecula, CA, USA) and was bisulfite
treated and run with the methylation assay. The positive
control was used to ensure bisulfite conversion and
accuracy of methylation measurement. The positive
control DNA was almost completely methylated as ex-
pected. Inter-chip variability was assessed and was found
to be highly reproducible. Pearson correlation coeffi-
cients were greater than 0.99 for each set of replicates
(P < 0.0001). Internal validity was assessed by examining
gender specific methylation of six X-linked housekeep-
ing genes (EFNB1, ELK1, FMR1, G6PD, GPC3, GLA)
[27,28]. Overall, methylation of the six aforementioned
housekeeping genes was as expected in that females ex-
hibited hemimethylation and males had very little
methylation at the loci in these genes (P < 0.0001 for
each gene).
Locus-specific methylation of the IGF1 CpG site was
validated on a subset of the original sample (N = 61)
using pyrosequencing. EpigenDX (Worcester, MA, USA)
designed and conducted the pyrosequencing assay ac-
cording to manufacturer’s instructions. The correlation
between the two measures of methylation (pyrosequenc-
ing and the Infinium HumanMethylation27 BeadArray)
was evaluated using Pearson’s correlation coefficient.
The two measures of methylation were significantly cor-
related (r = 0.36, P = 0.005).
Statistical analyses
SAS version 9.2 (SAS Institute, Cary, NC, USA) was
used to perform all analyses. All hypothesis tests were
two-tailed with a type 1 error rate fixed at 5%. Demo-
graphic and health characteristics were compared using
Fisher’s exact test, t-tests, and the Wilcoxon-Mann–
Whitney test as appropriate.
Multiple linear regression was used to examine DNA
methylation as a mediator of the association betweenrace and birth weight. Thus, the main outcome of inter-
est was birth weight. Since birth weight varies signifi-
cantly with gestational age, birth weight was regressed
onto gestational age. The residual values from each fit
were added to the mean birth weight and used to repre-
sent the gestational aBW. The gestational age-adjusted
birth weight variable did not initially meet all the as-
sumptions of linear regression; therefore, it was log
transformed to achieve normality. The log-transformed
aBW was ultimately used as the main outcome variable
and is interpreted as the percent change (100*coefficient)
in aBW for a one-unit increase in the dependent vari-
able. A secondary outcome, methylation of IGF1 was
also examined in relation to race. In order to simplify in-
terpretation, the Illumina beta values for IGF1 methyla-
tion were converted to z-scores. Potential confounders
were included in the adjusted models if the point esti-
mate changed by more than 10% after adjusting for the
confounder.
Mediation analysis was conducted using the methods
and macro developed by Valeri and VanderWeele [18].
This framework allowed for the decomposition of a total
effect into direct and indirect effects, so that we could
statistically test mediation of the race-aBW relationship
by IGF1 methylation. This method uses a model based
on two regression equations representing relationships
given in Figure 2B:
M ¼ y0 þ α xð Þ þ δ cð Þ þ e0 ð1Þ
Y ¼ y1 þ χ xð Þ þ β mð Þ þ δ0 cð Þ þ e1 ð2Þ
where Y is the dependent variable (log-transformed ges-
tational age-adjusted birth weight), x is the independent
variable (race), M is the mediator (IGF1 methylation sta-
tus), y0 and y1 are intercepts, e0 and e1 are the corre-
sponding residuals, and c are covariates. In this model,
χ is defined as the controlled direct effect relating the
independent variable (race) to the dependent variable
(log(aBW)) adjusted for the mediator (IGF1 methylation
status) and relevant covariates. The natural indirect
effect is the product α× β that is used to test the statistical
significance of the mediation model.
An important property of the natural indirect effect
and the controlled direct effect is that they can be re-
lated to the total effect (Figure 2A), defined as
Y ¼ y1 þ χ 0 xð Þ þ δ0 cð Þ þ e2 ð3Þ
which relates the independent variable (race) and the
dependent variable (log(aBW)), such that
α × β is equivalent to χ ’ − χ (the difference between
the total effect and the controlled direct effect).
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